Skip to main content

Table 1 Clinical and analytical characteristics of the cohort

From: The angiogenic properties of human amniotic membrane stem cells are enhanced in gestational diabetes and associate with fetal adiposity

  NGT (N = 14) GDM (N = 14) P-value
Maternal clinical and analytical characteristics
Maternal age (years) 33.86 ± 6.97 36.57 ± 3.65 0.208
Pregestational BMI (kg/m2) 25.27 ± 3.29 30.33 ± 5.93 0.010
Gestational weight gain (kg) 12.37 ± 4.51 8.21 ± 6.10 0.051
Nulliparous, n (%) 6 (43) 2 (14) 0.092
Glucose (mg/dL) 4.88 ± 1.94 4.65 ± 1.03 0.704
Offspring clinical and analytical characteristics
Gestational week delivery (weeks) 37.71 ± 0.73 38.07 ± 0.47 0.136
Birth weight (g) 3.265.36 ± 330.32 3.318.93 ± 379.89 0.694
Placental weight (g) 632.86 ± 47.51 675.00 ± 193.24 0.586
Sum skinfolds (mm) 12.47 ± 1.09 12.67 ± 2.20 0.773
Cb glucose (mg/dL) 3.57 ± 0.58 3.78 ± 0.78 0.437
Cb insulin mUI/L 33.89 ± 23.36 58.75 ± 50.83 0.295
Cb C peptide ng/dL 0.24 ± 0.06 0.27 ± 0.17 0.548
  1. Data expressed as mean ± SD for quantitative variables following normal distribution, qualitative variables are expressed as n (%). Differences between quantitative variables were assessed by Student’s t test or the Mann–Whitney U test, as required. Differences between qualitative variables were assessed by the Chi-square test
  2. The table should appear in the “Clinical and analytical characteristics of the cohort” subsection, inside the “Results”
  3. NGT normal glucose tolerance, GDM gestational diabetes mellitus, BMI body mass index, Cb Cord blood